Strongyloidiasis in immigrants and refugees in Canada.
作者信息
Thompson Courtney, Boggild Andrea K
机构信息
Department of Medicine (Thompson, Boggild), University of Toronto; Public Health Ontario Laboratories (Boggild), Public Health Ontario; Tropical Disease Unit (Boggild), Division of Infectious Diseases, Toronto General Hospital, University Health Network, Toronto, Ont.
出版信息
CMAJ. 2015 Dec 8;187(18):1389. doi: 10.1503/cmaj.141441. Epub 2015 Jul 6.
Abstract
摘要
相似文献
1
Strongyloidiasis in immigrants and refugees in Canada.
CMAJ. 2015 Dec 8;187(18):1389. doi: 10.1503/cmaj.141441. Epub 2015 Jul 6.
2
Management of chronic strongyloidiasis in immigrants and refugees: is serologic testing useful?
Am J Trop Med Hyg. 2009 May;80(5):788-91.
3
Ivermectin Treatment for Strongyloidiasis in Thailand.
Am J Trop Med Hyg. 2024 Jul 2;111(3):703. doi: 10.4269/ajtmh.24-0259.
4
Successful use of parenteral ivermectin in an immunosuppressed patient with disseminated strongyloidiasis and septic shock.
Intensive Care Med. 2005 Sep;31(9):1292. doi: 10.1007/s00134-005-2725-y. Epub 2005 Jul 22.
5
Comparison of Trials Using Ivermectin for COVID-19 Between Regions With High and Low Prevalence of Strongyloidiasis: A Meta-analysis.
JAMA Netw Open. 2022 Mar 1;5(3):e223079. doi: 10.1001/jamanetworkopen.2022.3079.
6
Constipation and weight loss in a Honduran immigrant.
Gastroenterology. 2015 Jun;148(7):e3-4. doi: 10.1053/j.gastro.2014.11.005. Epub 2015 Apr 30.
7
Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin.
Clin Infect Dis. 2005 Jul 1;41(1):e5-8. doi: 10.1086/430827. Epub 2005 May 11.
8
[Clinical and epidemiological characteristics of strongyloidiasis in patients with comorbidities].
Rev Chilena Infectol. 2017 Feb;34(1):47-53. doi: 10.4067/S0716-10182017000100007.
9
Human strongyloidiasis: often brushed under the carpet.
Trop Gastroenterol. 2009 Jan-Mar;30(1):1-4.
10
[Subcutaneous ivermectin in disseminated strongyloidiasis: A veterinary preparation authorised for human use].
Med Clin (Barc). 2016 Apr 15;146(8):376-7. doi: 10.1016/j.medcli.2015.10.008. Epub 2015 Dec 2.
引用本文的文献
1
Strongyloidiasis.
Nat Rev Dis Primers. 2024 Jan 25;10(1):6. doi: 10.1038/s41572-023-00490-x.
2
Inflammatory bowel disease later diagnosed as strongyloides colitis in migrants to Canada: a case series.
Ther Adv Infect Dis. 2023 Mar 29;10:20499361231162719. doi: 10.1177/20499361231162719. eCollection 2023 Jan-Dec.
3
Using newly optimized genetic tools to probe Strongyloides sensory behaviors.
Mol Biochem Parasitol. 2022 Jul;250:111491. doi: 10.1016/j.molbiopara.2022.111491. Epub 2022 Jun 10.
4
2018 in review: five hot topics in tropical medicine.
Trop Dis Travel Med Vaccines. 2019 Apr 15;5:5. doi: 10.1186/s40794-019-0082-z. eCollection 2019.
5
Implementation and evaluation of a quality and safety tool for ambulatory strongyloidiasis patients at high risk of adverse outcome.
Trop Dis Travel Med Vaccines. 2019 Apr 3;5:3. doi: 10.1186/s40794-019-0080-1. eCollection 2019.
本文引用的文献
1
Diagnostic accuracy of five serologic tests for Strongyloides stercoralis infection.
PLoS Negl Trop Dis. 2014 Jan 9;8(1):e2640. doi: 10.1371/journal.pntd.0002640. eCollection 2014.
2
Strongyloides stercoralis infection.
BMJ. 2013 Jul 30;347:f4610. doi: 10.1136/bmj.f4610.
3
Strongyloides stercoralis: Global Distribution and Risk Factors.
PLoS Negl Trop Dis. 2013 Jul 11;7(7):e2288. doi: 10.1371/journal.pntd.0002288. Print 2013.
4
Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis.
PLoS Negl Trop Dis. 2011 May 10;5(5):e1044. doi: 10.1371/journal.pntd.0001044.
5
Evidence-based clinical guidelines for immigrants and refugees.
CMAJ. 2011 Sep 6;183(12):E824-925. doi: 10.1503/cmaj.090313. Epub 2010 Jun 7.
Zotero 插件